What are the risk factors for developing a fistula in ano, particularly in adults with a history of anal abscesses or anorectal diseases such as Crohn's disease or ulcerative colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Fistula in Ano

The primary risk factor for developing a fistula in ano is a preceding anorectal abscess, which leads to fistula formation in approximately 33-50% of cases, with Crohn's disease being the most important underlying disease predisposition. 1, 2

Major Risk Factors

Anorectal Abscess (Most Common)

  • The majority of anal fistulae arise from preexisting abscesses and represent a spectrum of the same cryptoglandular disease process. 3, 1
  • Anorectal abscesses result from infection of the intersphincteric anal glands, with obstruction of the draining duct producing infection that can rupture through the external sphincter. 3
  • The recurrence rate after simple abscess drainage can be as high as 44%, with inadequate drainage, loculations, and time from disease onset to incision being key risk factors for fistula development. 1
  • Approximately 40% of anorectal abscesses progress to fistula formation. 2

Crohn's Disease (Most Important Underlying Condition)

  • Perianal fistulae occur in 13-27% of patients with Crohn's disease, making it the most significant disease-associated risk factor. 3
  • Perianal fistulae may be the initial manifestation of Crohn's disease in up to 81% of patients who develop perianal disease. 3
  • In a small subset of patients, perianal fistula is the only manifestation of their Crohn's disease. 3
  • Complex and multifocal fistulae are more common in Crohn's disease compared to cryptoglandular fistulae. 3
  • Crohn's colitis is associated with anal lesions much more frequently than small bowel Crohn's disease (52% vs. 14%). 4
  • It is mandatory to exclude underlying Crohn's disease, especially with recurrent presentations, by assessing for inflammatory bowel disease symptoms including diarrhea, weight loss, and abdominal pain. 1

Additional Risk Factors

Infectious and Inflammatory Conditions

  • Radiation proctitis can predispose to fistula formation. 3
  • Specific infections including HIV, tuberculosis, and actinomycosis are associated with anal fistula development. 3

Iatrogenic and Traumatic Factors

  • Prior anal surgery increases fistula risk. 3
  • Foreign body penetration can lead to fistula formation. 3

Malignancy-Associated Risk

  • Approximately 11% of colovesical and colovaginal fistulae are caused by malignancy. 3
  • Carcinoma has been reported in association with anal fistulae in Crohn's disease, and carcinomas may rarely arise in chronic fistulae. 3

Demographic Risk Factors

  • Male sex (2:1 male-to-female ratio). 3
  • Mean age at presentation is 40 years. 3

Clinical Pitfalls to Avoid

  • When an anal lesion is the manifesting sign, Crohn's disease will soon develop elsewhere in the intestine, so physicians must always consider inflammatory bowel disease when dealing with suspicious anal lesions. 4
  • The absence of acute infection (no swelling, fever, or leukocytosis) suggests a chronic fistula rather than an active abscess. 1
  • Concern for malignancy should be raised when imaging shows a soft mass, mass-like thickening of the anorectal wall, or malignant-appearing lymphadenopathy during evaluation for suspected benign inflammatory disease. 3

References

Guideline

Diagnosis and Management of Intersphincteric Fistula

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anorectal infection: abscess-fistula.

Clinics in colon and rectal surgery, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anal complications in Crohn's disease.

Diseases of the colon and rectum, 1981

Related Questions

What is the treatment for a painful anal abscess with hardened surrounding skin?
What is the treatment for an anal abscess?
What is the initial management for a patient with an anal fistula and a perianal fluid collection?
What is the diagnosis for a patient with perianal discharge, history of perianal abscess (anorectal abscess) drained twice, cord-like structure on digital rectal examination (DRE), internal opening at the dentate line on proctoscopy, without swelling, fever, or leukocytosis (elevated white blood cell count)?
What is the best management approach for a 33-year-old patient with Crohn's disease, presenting with a lateral anorectal mass, history of fistula and failed seton placement, currently afebrile and taking Augmentin (amoxicillin/clavulanate) for a tooth abscess?
What is the appropriate management of furosemide (Lasix) administration in a patient with potential fluid overload after a blood transfusion, considering their underlying medical conditions, such as heart failure or impaired renal (kidney) function?
What is the management plan for an elderly patient with a focal intraparenchymal hemorrhage in the left occipital region and a small subdural hematoma, presenting with potential neurocognitive issues and a history of trauma?
What is the diagnosis and treatment approach for a patient with suspected sarcoidosis?
What is the atypical coverage of meropenem and what alternative regimens can be used for patients with a history of antibiotic resistance or allergy?
What are the diagnostic criteria for craniometaphyseal dysplasia in a pediatric patient with a potential family history of similar conditions?
What is the optimal approach to haemodynamic (hemodynamic) monitoring in patients with a history of cirrhosis, portal hypertension, and comorbidities such as diabetes and cardiovascular disease undergoing liver transplantation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.